Literature DB >> 17671743

Association between genetic polymorphisms in the cyclooxygenase-1 gene promoter and peptic ulcers in Japan.

Tomiyasu Arisawa1, Tomomitsu Tahara, Tomoyuki Shibata, Mitsuo Nagasaka, Masakatsu Nakamura, Yoshio Kamiya, Hiroshi Fujita, Masahiko Nakamura, Daisuke Yoshioka, Yuko Arima, Masaaki Okubo, Ichiro Hirata, Hiroshi Nakano.   

Abstract

Cyclooxygenase-1 (COX-1) has been regarded as a constitutively expressed enzyme that generates prostaglandins for gastrointestinal integrity. We attempted to clarify the association between potentially functional polymorphisms (T-1676C and A-842G/C50T) in the COX-1 gene promoter and gastroduodenal disorders in a Japanese population. The study was performed with 480 stocked DNAs from subjects (gastric ulcers in 93 subjects and duodenal ulcers in 44) with no evidence of gastric malignancy. We employed the PCR-SSCP method to detect gene polymorphisms. The severity of histological chronic gastritis in antral biopsy specimens was classified according to the updated Sydney system. The T-1676C polymorphism was not associated with either gastric mucosal atrophy or infiltration of inflammatory cells into gastric mucosa. In non-NSAID (non-steroidal anti-inflammatory drug) users, male gender and Helicobacter pylori (HP) infection were significantly associated with both gastric and duodenal ulcers, whereas the -1676T allele carrier was significantly associated with only gastric ulcers (OR, 2.86; 95% CI, 1.29-6.34). In NSAID users, the number of -1676T alleles was significantly associated with developing gastroduodenal ulcers (OR, 5.80; 95% CI, 1.59-21.1), whereas male gender and HP infection were not. The -842T/ C50T polymorphism was not detected in any of the 480 Japanese subjects. In conclusion, a carrier of the -1676T allele in the COX-1 gene promoter, as well as HP infection and male gender, seem to be significant risk factors for developing gastric ulcers, and the number of -1676T alleles was also a significant risk factor for the NSAID-induced ulcer, whereas the frequency of the A-842G polymorphism was thought to be very rare in the Japanese population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17671743

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  11 in total

1.  Telomere length in non-neoplastic gastric mucosa and its relationship to H. pylori infection, degree of gastritis, and NSAID use.

Authors:  Tomomitsu Tahara; Tomoyuki Shibata; Tomohiko Kawamura; Takamitsu Ishizuka; Masaaki Okubo; Mitsuo Nagasaka; Yoshihito Nakagawa; Tomiyasu Arisawa; Naoki Ohmiya; Ichiro Hirata
Journal:  Clin Exp Med       Date:  2015-01-07       Impact factor: 3.984

2.  Hemorrhagic gastric and duodenal ulcers after the Great East Japan Earthquake Disaster.

Authors:  Kenichi Yamanaka; Hiroyuki Miyatani; Yukio Yoshida; Shinichi Asabe; Toru Yoshida; Misaki Nakano; Shin Obara; Hidehiko Endo
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

3.  The preventive factors for aspirin-induced peptic ulcer: aspirin ulcer and corpus atrophy.

Authors:  Akiko Shiotani; Takashi Sakakibara; Yoshiyuki Yamanaka; Ryuji Nishi; Hiroshi Imamura; Minoru Fujita; Ken-ichi Tarumi; Tomoari Kamada; Jiro Hata; Ken Haruma
Journal:  J Gastroenterol       Date:  2009-05-16       Impact factor: 7.527

Review 4.  Interaction between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs and/or low-dose aspirin use: old question new insights.

Authors:  Carlos Sostres; Carla Jerusalen Gargallo; Angel Lanas
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

5.  Genetic variants associated with development of TMD and its intermediate phenotypes: the genetic architecture of TMD in the OPPERA prospective cohort study.

Authors:  Shad B Smith; Ellen Mir; Eric Bair; Gary D Slade; Ronald Dubner; Roger B Fillingim; Joel D Greenspan; Richard Ohrbach; Charles Knott; Bruce Weir; William Maixner; Luda Diatchenko
Journal:  J Pain       Date:  2013-12       Impact factor: 5.820

6.  Impact of PSCA variation on gastric ulcer susceptibility.

Authors:  Chizu Tanikawa; Keitaro Matsuo; Michiaki Kubo; Atsushi Takahashi; Hidemi Ito; Hideo Tanaka; Yasushi Yatabe; Kenji Yamao; Naoyuki Kamatani; Kazuo Tajima; Yusuke Nakamura; Koichi Matsuda
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

7.  Impact of blood type, functional polymorphism (T-1676C) of the COX-1 gene promoter and clinical factors on the development of peptic ulcer during cardiovascular prophylaxis with low-dose aspirin.

Authors:  Pin-Yao Wang; Hsiu-Ping Chen; Angela Chen; Feng-Woei Tsay; Kwok-Hung Lai; Sung-Shuo Kao; Wen-Chi Chen; Chao-Hung Kuo; Nan-Jing Peng; Hui-Hwa Tseng; Ping-I Hsu
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

Review 8.  Aspirin and Colorectal Cancer Prevention and Treatment: Is It for Everyone?

Authors:  Christopher Coyle; Fay Helen Cafferty; Ruth Elizabeth Langley
Journal:  Curr Colorectal Cancer Rep       Date:  2016-02-11

9.  The IL-1B Genetic Polymorphism Is Associated with Aspirin-Induced PepticUlcers in a Korean Ethnic Group.

Authors:  Jae Hee Cho; Ja Sung Choi; Song Wook Chun; Sangheun Lee; Ki Jun Han; Hee Man Kim
Journal:  Gut Liver       Date:  2016-05-23       Impact factor: 4.519

Review 10.  Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity.

Authors:  L McEvoy; D F Carr; M Pirmohamed
Journal:  Front Pharmacol       Date:  2021-06-21       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.